Cited 10 times in
17-year trends of body mass index, overweight, and obesity among adolescents from 2005 to 2021, including the COVID-19 pandemic: a Korean national representative study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신재일 | - |
dc.date.accessioned | 2023-04-20T08:20:22Z | - |
dc.date.available | 2023-04-20T08:20:22Z | - |
dc.date.issued | 2023-02 | - |
dc.identifier.issn | 1128-3602 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194070 | - |
dc.description.abstract | OBJECTIVE: There is a lack of pediatric studies that have analyzed trends in mean body mass index (BMI) and the prevalence of obesity and overweight over a period that includes the mid-stage of the COVID-19 pandemic. Thus, we aimed to investigate trends in BMI, overweight, and obesity among Korean adolescents from 2005 to 2021, including the COVID-19 pandemic. SUBJECTS AND METHODS: We used data from the Korea Youth Risk Behavior Web-based Survey (KYRBS), which is nationally representative of South Korea. The study included middle- and high-school students between the ages of 12 and 18. We examined trends in mean BMI and prevalence of obesity and/or overweight during the COVID-19 pandemic and compared these to those of pre-pandemic trends in each subgroup by gender, grade, and residential region. RESULTS: Data from 1,111,300 adolescents (mean age: 15.04 years) were analyzed. The estimated weighted mean BMI was 20.48 kg/m2 (95% CI, 20.46-20.51) between 2005 and 2007, and this was 21.61 kg/m2 (95% CI, 21.54-21.68) in 2021. The prevalence of overweight and obesity was 13.1% (95% CI, 12.9-13.3%) between 2005 and 2007 and 23.4% (95% CI, 22.8-24.0%) in 2021. The mean BMI and prevalence of obesity and overweight have gradually increased over the past 17 years; however, the extent of change in mean BMI and in the prevalence of obesity and overweight during the pandemic was distinctly less than before. The 17-year trends in the mean BMI, obesity, and overweight exhibited a considerable rise from 2005 to 2021; however, the slope during the COVID-19 pandemic (2020-2021) was significantly less prominent than in the pre-pandemic (2005-2019). CONCLUSIONS: These findings enable us to comprehend long-term trends in the mean BMI of Korean adolescents and further emphasize the need for practical prevention measures against youth obesity and overweight. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Verduci | - |
dc.relation.isPartOf | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Adolescent | - |
dc.subject.MESH | Body Mass Index | - |
dc.subject.MESH | COVID-19* | - |
dc.subject.MESH | Child | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Obesity | - |
dc.subject.MESH | Overweight* | - |
dc.subject.MESH | Pandemics | - |
dc.subject.MESH | Republic of Korea | - |
dc.title | 17-year trends of body mass index, overweight, and obesity among adolescents from 2005 to 2021, including the COVID-19 pandemic: a Korean national representative study | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pediatrics (소아과학교실) | - |
dc.contributor.googleauthor | C Y Ban | - |
dc.contributor.googleauthor | H Shin | - |
dc.contributor.googleauthor | S Eum | - |
dc.contributor.googleauthor | H Yon | - |
dc.contributor.googleauthor | S W Lee | - |
dc.contributor.googleauthor | Y S Choi | - |
dc.contributor.googleauthor | Y H Shin | - |
dc.contributor.googleauthor | J U Shin | - |
dc.contributor.googleauthor | A Koyanagi | - |
dc.contributor.googleauthor | L Jacob | - |
dc.contributor.googleauthor | L Smith | - |
dc.contributor.googleauthor | C Min | - |
dc.contributor.googleauthor | A Ö Yeniova | - |
dc.contributor.googleauthor | S Y Kim | - |
dc.contributor.googleauthor | J Lee | - |
dc.contributor.googleauthor | S-G Yeo | - |
dc.contributor.googleauthor | R Kwon | - |
dc.contributor.googleauthor | M J Koo | - |
dc.contributor.googleauthor | G Fond | - |
dc.contributor.googleauthor | L Boyer | - |
dc.contributor.googleauthor | K P Acharya | - |
dc.contributor.googleauthor | S Kim | - |
dc.contributor.googleauthor | H G Woo | - |
dc.contributor.googleauthor | S Park | - |
dc.contributor.googleauthor | J I Shin | - |
dc.contributor.googleauthor | S Y Rhee | - |
dc.contributor.googleauthor | D K Yon | - |
dc.identifier.doi | 10.26355/eurrev_202302_31399 | - |
dc.contributor.localId | A02142 | - |
dc.relation.journalcode | J03872 | - |
dc.identifier.eissn | 2284-0729 | - |
dc.identifier.pmid | 36876712 | - |
dc.contributor.alternativeName | Shin, Jae Il | - |
dc.contributor.affiliatedAuthor | 신재일 | - |
dc.citation.volume | 27 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1565 | - |
dc.citation.endPage | 1575 | - |
dc.identifier.bibliographicCitation | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, Vol.27(4) : 1565-1575, 2023-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.